Complications of Endovascular Treatment for Acute Stroke in the SWIFT Trial with Solitaire and Merci Devices

REFERENCES

1. 1.↵
   National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–87

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Rha J,
   2. Saver JL

   . The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 2007;38:967–73

   Abstract/FREE Full Text
3. 3.↵
   1. Tenser MS,
   2. Amar AP,
   3. Mack WJ

   . Mechanical thrombectomy for acute ischemic stroke using the Merci retriever and Penumbra aspiration systems. World Neurosurg 2011;76(6 Suppl):S16–23

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Del Zoppo GJ,
   2. Higashida RT,
   3. Furlan AJ,
   4. et al.

   , and the PROACT Investigators. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 1998;29:4–11

   Abstract/FREE Full Text
5. 5.↵
   1. Furlan A,
   2. Higashida R,
   3. Wechsler L,
   4. et al.

   , for the PROACT Investigators. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II Study: a randomized controlled trial JAMA 1999;282:2003–11

   CrossRefPubMedWeb of Science
6. 6.↵
   IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 2004;35:904–11

   Abstract/FREE Full Text
7. 7.↵
   1. Smith WS,
   2. Sung G,
   3. Starkman S,
   4. et al.

   , for the MERCI Trial Investigators. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI Trial. Stroke 2005;36:1432–40

   Abstract/FREE Full Text
8. 8.↵
   IMS II Trial Investigators. The Interventional Management of Stroke (IMS) II Study. Stroke 2007;38:2127–35

   Abstract/FREE Full Text
9. 9.↵
   1. Bose A,
   2. Henkes H,
   3. Alfke K,
   4. et al.

   , for the Penumbra Phase 1 Stroke Trial Investigators. The Penumbra system: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol 2008;29:1409–13

   Abstract/FREE Full Text
10. 10.↵
    1. Smith WS,
    2. Sung G,
    3. Saver J,
    4. et al.

    , Multi MERCI Investigators. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008;39:1205–12

    Abstract/FREE Full Text
11. 11.↵
    1. Miteff F,
    2. Faulder KC,
    3. Goh AC,
    4. et al

    . Mechanical thrombectomy with a self-expanding retrievable intracranial stent (Solitaire AB): experience in 26 patients with acute cerebral occlusion. AJNR Am J Neuroradiol 2011;32:1078–81

    Abstract/FREE Full Text
12. 12.↵
    1. Machi P,
    2. Costalat V,
    3. Lobotesis K,
    4. et al

    . Solitaire FR thrombectomy system: immediate results in 56 consecutive acute ischemic stroke patients. J Neurointerv Surg 2012;4:62–66

    Abstract/FREE Full Text
13. 13.↵
    1. Saver JL,
    2. Jahan R,
    3. Levy EI,
    4. et al.

    , for the SWIFT trialists. Solitaire flow restoration device versus the Merci retriever in patients with acute ischaemic stroke (SWIFT): a randomized, parallel-group, non-inferiority trial. Lancet 2012;380:1241–49

    CrossRefPubMedWeb of Science
14. 14.↵
    TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I findings. N Engl J Med 1984;33:523–30
15. 15.↵
    Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0, DCTD, NCI, NIH, DHHS March 31, 2003. (http://ctep.cancer.gov), Publish Date: August 9, 2006.
16. 16.↵
    1. Hacke W,
    2. Kaste M,
    3. Fieschi C,
    4. et al.

    , for the ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017–25

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Shi Z-S,
    2. Liebeskind DS,
    3. Loh Y,
    4. et al.

    , and UCLA Endovascular Stroke Therapy Investigators. Predictors of subarachnoid hemorrhage in acute ischemic stroke with endovascular therapy. Stroke 2010;41:2775–81

    Abstract/FREE Full Text
18. 18.↵
    1. Khatri P,
    2. Broderick JP,
    3. Khoury JC,
    4. et al.

    , IMS I and II Investigators. Microcatheter contrast injections during intra-arterial thrombolysis may increase intracranial hemorrhage risk. Stroke 2008;39:3283–87

    Abstract/FREE Full Text
19. 19.↵
    1. Teal PA,
    2. Pessin MS

    . Hemorrhagic transformation: the spectrum of ischemia-related brain hemorrhage. Neurosurg Clin North Am 1992;3:601–10

    PubMed
20. 20.↵
    1. Mehra M,
    2. Hendricks GH,
    3. O'Callaghan JM,
    4. et al

    . Preclinical in-vivo safety evaluation of thrombectomy devices in the canine cerebrovasculature (abstract). Stroke 2012;43:A139
21. 21.↵
    1. Broderick JP,
    2. Palesch YY,
    3. Demchuk AM,
    4. et al.

    , for the IMS III Investigators. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013;368:893–903

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Pausch R

    . The Last Lecture. New York: Hyperion Books; 2008